Eli Lilly CEO David Ricks Just Delivered Terrible News to Investors: Should You Sell the Stock?

As everyone who follows equity markets knows, stocks are feeling the heat from President Donald Trump's macroeconomic policies. On April 3, the president announced sweeping tariffs on goods imported into the U.S. from basically every country on planet Earth.Some industries have escaped these moves by the administration, at least for now. One of them is the pharmaceutical industry. However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks.Let's see what he had to say about the potential impact of tariffs, and what they could mean for those thinking about investing in the company.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool